|
Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia
|
Jan 2013
|
Blood
|
aplastic anemia
|
|
Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48(1):63-70
|
Nov 2016
|
Blood
|
aplastic anemia
|
|
Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children
|
Jan 2013
|
Blood
|
aplastic anemia
|
|
Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria
|
Jun 2015
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
How I treat acquired aplastic anemia
|
Jan 2012
|
Blood
|
aplastic anemia
|
|
Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution
|
Apr 2019
|
Blood
|
aplastic anemia
|
|
Eltrombopag restores tri-lineage hematopoiesis in refractory severe aplastic anemia which can be sustained on discontinuation of drug
|
Dec 2013
|
Blood
|
aplastic anemia
|
|
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage specific expansion and harbor genetic and epigenetic alterations.
|
Jul 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Origins of myelodysplastic syndromes after aplastic anemia
|
Sep 2017
|
Blood
|
aplastic anemia
|
|
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria
|
Feb 2014
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
